Cuffe, M S <br/><br/>
Rationale and design of the OPTIME CHF trial: outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure.  [electronic resource] 

 -  American heart journal  Jan 2000 
 - 15-22 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0002-8703 
<br/><br/><label>Standard No.: </label>10.1016/s0002-8703(00)90303-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Cost-Benefit Analysis<br/>Female<br/>Heart Failure--drug therapy<br/>Hospital Mortality<br/>Humans<br/>Injections, Intravenous<br/>Length of Stay<br/>Male<br/>Milrinone--administration & dosage<br/>Phosphodiesterase Inhibitors--administration & dosage<br/>Prospective Studies<br/>Quality of Life<br/>Survival Rate<br/>Treatment Outcome<br/>United States--epidemiology